A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 101,128 shares of TSVT stock, worth $314,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,128
Previous 116,847 13.45%
Holding current value
$314,508
Previous $449,000 6.24%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.85 - $5.05 $60,518 - $79,380
-15,719 Reduced 13.45%
101,128 $477,000
Q2 2024

Aug 14, 2024

BUY
$3.6 - $5.79 $420,649 - $676,544
116,847 New
116,847 $449,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $118M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.